Lobe Sciences Ltd. (LOBEF)
Develops lipid-based treatments for rare blood disorders like sickle cell disease.
$0.07+9.91%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+1985.3%
The outlook
LOBEF is trading near its 52-week high after a strong day, sitting above both its 50- and 200-day moving averages. Analyst coverage appears thin, so independent research would be important. The current price momentum and technical positioning reflect recent upward movement, though past performance doesn't indicate future results.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$21.9M
52-wk high
$0.07
52-wk low
$0.00
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
—